Skip to main content
Top
Published in: Acta Diabetologica 8/2020

01-08-2020 | Angiography | Original Article

Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy

Authors: Marco Lupidi, Alessio Cerquaglia, Ramkailash Gujar, Daniela Fruttini, Felice Cardillo Piccolino, Tito Fiore, Florence Coscas, Gabriel Coscas, Jay Chhablani, Carlo Cagini

Published in: Acta Diabetologica | Issue 8/2020

Login to get access

Abstract

Aims

To perform an automated functional assessment of retinal and choroidal microvasculature in eyes with low-grade diabetic retinopathy (DR) using optical coherence tomography angiography (OCT-A) and to identify potential perfusion changes in case of early vascular damage.

Methods

This is an observational, case–control study of consecutive diabetic patients with level 20 DR severity scale score and age-matched healthy subjects. A prototypal OCT-angiography was used to obtain the OCT-angiograms of the superficial capillary plexus (SCP), deep capillary plexus (DCP) and choriocapillaris (CC) layer. A validated automated microstructural analysis provided data on SCP, DCP and CC vascular perfusion density (VPD). A comparative assessment between different vascular layers and different groups was performed.

Results

Twenty-nine diabetic patients (7 females, 24%) and 20 healthy controls were enrolled. VPD values were significantly lower in the DCP (25.1% vs. 26.5%; p = 0.04) and CC (71.2% vs. 86.6%; p = 0.0001) of diabetic patients compared with controls. A statistically significant negative linear correlation was reported between CC VPD and DCP VPD in diabetic patients; at the reverse, a positive linear correlation between the same parameters was noticed in controls.

Conclusion

Retinal and choroidal vascular networks, although distinct entities, seem functionally interconnected: varying the degree of perfusion may be a mutual compensatory mechanism in response to an ischemic injury.
Literature
1.
go back to reference Klein R, Klein BE, Moss SE et al (1994) The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217–1228CrossRef Klein R, Klein BE, Moss SE et al (1994) The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217–1228CrossRef
2.
go back to reference Engerman RL, Kern TS (1995) Retinopathy in animal models of diabetes. Diabetes Metab Rev 11:109–120CrossRef Engerman RL, Kern TS (1995) Retinopathy in animal models of diabetes. Diabetes Metab Rev 11:109–120CrossRef
3.
go back to reference Hammes HP, Lin JH, Renner O et al (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51:3107–3112CrossRef Hammes HP, Lin JH, Renner O et al (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51:3107–3112CrossRef
4.
go back to reference Hidayat A, Fine B (1985) Diabetic choroidopathy: light and electron microscopic observations of seven cases. Ophthalmology 67:512–522CrossRef Hidayat A, Fine B (1985) Diabetic choroidopathy: light and electron microscopic observations of seven cases. Ophthalmology 67:512–522CrossRef
6.
go back to reference Cao J, McLeod DS, Merges CA, Lutty GA (1998) Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 116:589–597CrossRef Cao J, McLeod DS, Merges CA, Lutty GA (1998) Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 116:589–597CrossRef
7.
go back to reference Weinberger D, Kramer M, Priel E et al (1998) Indocyanine green angiographic findings in nonproliferative diabetic retinopathy. Am J Ophthalmol 126:238–247CrossRef Weinberger D, Kramer M, Priel E et al (1998) Indocyanine green angiographic findings in nonproliferative diabetic retinopathy. Am J Ophthalmol 126:238–247CrossRef
8.
go back to reference Shiragami C, Shiraga F, Matsuo T et al (2002) Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 240(6):436–442CrossRef Shiragami C, Shiraga F, Matsuo T et al (2002) Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 240(6):436–442CrossRef
9.
go back to reference Hua R, Liu L, Wang X, Chen L (2013) Imaging evidence of diabetic choroidopathy in vivo: angiographic pathoanatomy and choroidal-enhanced depth imaging. PLoS ONE 8(12):e83494CrossRef Hua R, Liu L, Wang X, Chen L (2013) Imaging evidence of diabetic choroidopathy in vivo: angiographic pathoanatomy and choroidal-enhanced depth imaging. PLoS ONE 8(12):e83494CrossRef
10.
go back to reference Coscas G, Lupidi M, Coscas F (2017) Optical coherence tomography angiography in diabetic maculopathy. Dev Ophthalmol 60:38–49CrossRef Coscas G, Lupidi M, Coscas F (2017) Optical coherence tomography angiography in diabetic maculopathy. Dev Ophthalmol 60:38–49CrossRef
11.
go back to reference Ishibazawa A, Nagaoka T, Takahashi A et al (2015) Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol 160:35–44CrossRef Ishibazawa A, Nagaoka T, Takahashi A et al (2015) Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol 160:35–44CrossRef
12.
go back to reference Coscas G, Lupidi M, Coscas F, Chhablani J, Cagini C (2018) Optical coherence tomography angiography in healthy subjects and diabetic patients. Ophthalmologica 239(2–3):61–73CrossRef Coscas G, Lupidi M, Coscas F, Chhablani J, Cagini C (2018) Optical coherence tomography angiography in healthy subjects and diabetic patients. Ophthalmologica 239(2–3):61–73CrossRef
13.
go back to reference Lupidi M, Coscas G, Coscas F et al (2017) Retinal microvasculature in non-proliferative diabetic retinopathy: automated quantitative optical coherence tomography angiography assessment. Ophthalmic Res 58(3):131–141CrossRef Lupidi M, Coscas G, Coscas F et al (2017) Retinal microvasculature in non-proliferative diabetic retinopathy: automated quantitative optical coherence tomography angiography assessment. Ophthalmic Res 58(3):131–141CrossRef
14.
go back to reference Choi W, Waheed NK, Moult EM et al (2017) Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina 37(1):11–21CrossRef Choi W, Waheed NK, Moult EM et al (2017) Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina 37(1):11–21CrossRef
15.
go back to reference Carnevali A, Sacconi R, Corbelli E et al (2017) Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol 54(7):695–702CrossRef Carnevali A, Sacconi R, Corbelli E et al (2017) Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol 54(7):695–702CrossRef
16.
go back to reference Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs and extension of the modified Airlie house classification. ETDRS report number 10. Ophthalmology 98(5 suppl):786–806 Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs and extension of the modified Airlie house classification. ETDRS report number 10. Ophthalmology 98(5 suppl):786–806
17.
go back to reference Aiello LP, Beck RW, Bressler NM et al (2011) Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology 118(12):e5–e14CrossRef Aiello LP, Beck RW, Bressler NM et al (2011) Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology 118(12):e5–e14CrossRef
18.
go back to reference Cardillo Piccolino F, Lupidi M, Cagini C et al (2018) Choroidal vascular reactivity in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 59:3897–3905CrossRef Cardillo Piccolino F, Lupidi M, Cagini C et al (2018) Choroidal vascular reactivity in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 59:3897–3905CrossRef
19.
go back to reference Freund KB, Sarraf D, Leong BCS et al (2018) Association of optical coherence tomography angiography of collaterals in retinal vein occlusion with major venous outflow through the deep vascular complex. JAMA Ophthalmol 136(11):1262–1270CrossRef Freund KB, Sarraf D, Leong BCS et al (2018) Association of optical coherence tomography angiography of collaterals in retinal vein occlusion with major venous outflow through the deep vascular complex. JAMA Ophthalmol 136(11):1262–1270CrossRef
20.
go back to reference Vujosevic S, Martini F, Cavarzeran F, Pilotto E, Midena E (2012) Macular and peripapillary choroidal thickness in diabetic patients. Retina 32(9):1781–1790CrossRef Vujosevic S, Martini F, Cavarzeran F, Pilotto E, Midena E (2012) Macular and peripapillary choroidal thickness in diabetic patients. Retina 32(9):1781–1790CrossRef
21.
go back to reference Querques G, Lattanzio R, Querques L et al (2012) Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 53(10):6017CrossRef Querques G, Lattanzio R, Querques L et al (2012) Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 53(10):6017CrossRef
22.
go back to reference Nesper PL, Roberts PK, Onishi AC et al (2017) Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:BIO307–BIO315CrossRef Nesper PL, Roberts PK, Onishi AC et al (2017) Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography. Invest Ophthalmol Vis Sci 58:BIO307–BIO315CrossRef
23.
go back to reference Scarinci F, Nesper PL, Fawzi AA (2016) Deep retinal capillary nonperfusion is associated with photoreceptor disruption in diabetic macular ischemia. Am J Ophthalmol 168:129–138CrossRef Scarinci F, Nesper PL, Fawzi AA (2016) Deep retinal capillary nonperfusion is associated with photoreceptor disruption in diabetic macular ischemia. Am J Ophthalmol 168:129–138CrossRef
24.
go back to reference Birol G, Wang S, Budzynski E et al (2007) Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol 293(3):H1696–H1704CrossRef Birol G, Wang S, Budzynski E et al (2007) Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol 293(3):H1696–H1704CrossRef
26.
go back to reference Yi J, Liu W, Chen S et al (2015) Visible light optical coherence tomography measures retinal oxygen metabolic response to systemic oxygenation. Light Sci Appl 4:e334CrossRef Yi J, Liu W, Chen S et al (2015) Visible light optical coherence tomography measures retinal oxygen metabolic response to systemic oxygenation. Light Sci Appl 4:e334CrossRef
Metadata
Title
Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy
Authors
Marco Lupidi
Alessio Cerquaglia
Ramkailash Gujar
Daniela Fruttini
Felice Cardillo Piccolino
Tito Fiore
Florence Coscas
Gabriel Coscas
Jay Chhablani
Carlo Cagini
Publication date
01-08-2020
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2020
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01507-7

Other articles of this Issue 8/2020

Acta Diabetologica 8/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.